To assess the effect on glycated haemoglobin (GHb) of diabetes self-management education (DSME) for adults with type 2 diabetes mellitus. MEDLINE (from 1980 to December 1999), ERIC (from 1980 to 1999) and CINAHL (from 1982 to 1999 were searched for studies published in the English language; the search terms were stated. Abstracts and dissertations were not included. Journals of most relevance were handsearched and experts in the field were contacted for additional reports.
Participants included in the review
Studies in which all or most of the participants were adults (older than 18 years) with any severity of type 2 diabetes mellitus were eligible for inclusion. Studies that did not specify the type of diabetes mellitus but were in patients with a mean age of greater than 30 years were also included. Studies of patients with any co-morbidity were eligible. The included studies were of patients who were (16% of participants) or were not being treated with insulin. The mean age of the patients was 55 years and the mean baseline GHb was 9.4 (range: 6.1 to 12.9).
Outcomes assessed in the review
Studies that reported GHb (including HbA1 and HbA1c) were eligible for inclusion. The included studies used a variety of methods to measure GHb, e.g. ion-exchange and affinity chromatography.
How were decisions on the relevance of primary studies made?
The titles of identified studies were checked for relevance to diabetes education and full texts were obtained. The authors did not state how many reviewers performed the selection.
Assessment of study quality
Validity was assessed using the criteria described in the Cochrane Reviewers Handbook (see Other Publications of Related Interest). In addition, selection bias, attrition and detection bias were assessed. Attrition was considered to be potentially biased if the drop-out rate before data collection exceeded 20% of those recruited and the drop-outs either differed from completers or were not compared. The authors did not state how the papers were assessed for validity, or how many reviewers performed the validity assessment.
Data extraction
One reviewer extracted the data and a second reviewer checked the data. The data extractor was not blinded to the author or institution. Only data presented in the reports were included. The data extracted included: characteristics of the participants; diabetes treatment; baseline GHb; psychosocial variables; details of the intervention, e.g. the number of contacts, contact time, duration of the intervention, the person delivering and method of delivering the intervention; details of the control intervention; use of self-monitoring; type of health care system; and setting.
Data presented as HbA1 was converted to equivalent HbA1c where possible. The mean difference in GHb between the intervention and control groups was estimated for each study for three follow-up periods (immediately, 1 to 3 months, and at least 4 months after the intervention). Each study contributed only one result per follow-up period. Details of the methods used to estimate missing statistical data from whatever data were presented were reported. To estimate the variance of the difference in GHb between treatments, the correlation between baseline and follow-up GHB was required. None of the studies reported this value and, consequently, three different values were input for the correlation.
Methods of synthesis
How were the studies combined?
The pooled difference in GHb between the intervention and control groups was estimated using the random-effects model of DerSimonian and Laird for each of the three follow-up periods.
How were differences between studies investigated?
Statistical heterogeneity was tested using the chi-squared statistic. A sensitivity analysis was conducted using values of 0.25, 0.5 and 0.75 for the correlation between baseline and follow-up GHb in estimations of the variance of the difference between treatments. Studies that used only usual care as the control intervention were analysed separately.
A meta-regression was used to assess the influence on the results of the following: the time over which the intervention was delivered, the length of follow-up, the number of patient contacts, the total patient contact time, baseline GHb, treatment (insulin, diet only or oral hypoglyaemic agent), group versus individual intervention, age of the patient, person delivering the intervention, educational focus, follow-up interval, and setting (USA versus other countries). The metaanalysis was conducted with and without one study that was excluded from the main meta-analysis due to the use of an atypically intensive intervention for both treatment arms. Forest plots were presented for the change in GHb using a correlation of 0.5.
Results of the review
Thirty-one RCTs (4,263 patients) were included.
Compared with control interventions, DSME reduced GHb immediately after the intervention, at 1 to 3 months' followup and at 4 or more months' follow-up. However, the difference in GHb at 1 to 3 months was not statistically significant. The decrease in GHb post-intervention (2,056 patients) was 0.76% (95% confidence interval, CI: 0.34, 1.18). Heterogeneity was significant (P<0.05). The decrease at 1 to 3 months (922 patients) was 0.26% (0.21% increase to 0.73% decrease). The decrease at 4 or more months (1,893 patients) was 0.26% (95% CI: 0.05, 0.48).
The results were similar for the subgroup of studies that used usual care with no additional intervention as the control.
The results were independent of the value used for the correlation between baseline and follow-up GHb.
The only variable found to significantly influence the results was the total contact time. The decrease in GHb was greater with increased contact time: from 15 studies with 21 GHb measurements, there was a decrease of 0.04% for every additional hour of contact time over the range of 1 to 28 hours.
There were insufficient data to assess the influence of psychosocial variables on GHb. 
